CAM
URGN icon

Cormorant Asset Management’s UroGen Pharma URGN Stock Holding History

Cormorant Asset Management’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-300,000
Closed -$3.2M – 46
2024
Q4 		$3.2M Sell
300,000
-1,250,000
-81% -$13.3M 0.18% 42
2024
Q3 		$19.7M Sell
1,550,000
-100,000
-6% -$1.27M 1.04% 30
2024
Q2 		$27.7M Buy
+1,650,000
New +$27.7M 1.6% 22